New Regulation to Limit the Sale of Semaglutide

Back to list

New Regulation to Limit the Sale of Semaglutide

On April 19, 2023, Minister of Health Adrian Dix announced that a new regulation will be enacted immediately in order to prevent a shortage of the diabetes drug semaglutide, also known as Ozempic, in the province of British Columbia. The regulation will limit the sale of semaglutide to ensure that patients with diabetes in the province have access to this medication.

The College will be responsible for ensuring that all registrants comply with the new regulation. This means that pharmacies and pharmacy professionals must comply with the new regulation in order to ensure that patients in British Columbia have access to the medications they need. The College will work with the provincial government to ensure that all new regulatory requirements are met and that practice standards continue to be followed by every pharmacy professional in the province.

For more information about the new regulation, please refer to the Drug Schedules (Limits on Sale) Regulation.

Apr 20, 2023